Han Ximin

1824295095@qq.com

SHENZHEN’S MGI Tech Co., Ltd. will leverage its state-of-the-art DNBSEQ sequencers and automation platforms to revolutionize sports and anti-doping research at the Paris Olympics.

In collaboration with Professor Yannis Pitsiladis, a renowned geneticist from Hong Kong Baptist University and a member of the International Olympic Committee Medical and Scientific Commission, the partnership will utilize MGI’s cutting-edge DNBSEQ sequencers to detect drugs in sports, particularly focusing on blood doping.

During a panel discussion as part of a two-day program at Hong Kong Baptist University held at OLY House Paris 2024 @ Caisse d’Epargne today, MGI will showcase the portable DNBSEQ-E25 sequencer, ultra-high-speed DNBSEQ-G99, and AlphaTool automated pipetting robot, offering Olympians from around the world a preview of these advanced technologies, as reported by BGI on Friday.

“With an estimated 6% of top athletes using doping, additional detection methods are essential to eradicate this unethical practice,” stated Pitsiladis. “High throughput sequencing could significantly aid in identifying blood doping methods, including when they occurred. MGI’s advanced sequencing tools are streamlining what was once a labor-intensive, expensive, and time-consuming process,” he emphasized.

On July 22, Pitsiladis, in collaboration with MGI, published a perspective article on Translational Exercise Biomedicine. By outlining considerations for developing a transcriptomic test for blood doping, the article aims to support international research and anti-doping centers in implementing transcriptomic testing compliant with the World Anti-Doping Agency’s regulations.

“We are proud to contribute to valuable research in sports performance and anti-doping testing and to showcase our technologies at one of the most significant sporting events,” stated Yu Duncan, president of MGI. “With intelligent innovation at the core of MGI, we are dedicated to leveraging technologies for substantial advancements and to support pioneering applications in this field.”